Metraipolis › archive › dc_d9eb4e44bbc7

Triple M Syndrome Associated With Concurrent Durvalumab and Olaparib Therapy in Metastatic Cholangiocarcinoma: A Case Report — Europe PMC PMID:42338513

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42338513
DOI: 10.1155/crom/1318038
License (as archived): solo-consultazione
Archived: 2026-10-19T07:10:51.692Z
SHA-256 of the archived text: 715a177ebc10384640b035a48466cf837f7353819932da21ad05e04124bcc8d3
Stable URL of this page: https://metraipolis.com/documento/dc_d9eb4e44bbc7

How to cite

Triple M Syndrome Associated With Concurrent Durvalumab and Olaparib Therapy in Metastatic Cholangiocarcinoma: A Case Report — Europe PMC PMID:42338513 — Europe PMC (en), https://europepmc.org/article/MED/42338513 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d9eb4e44bbc7 (Metraipolis archive dc_d9eb4e44bbc7, sha256 715a177ebc10384640b035a48466cf837f7353819932da21ad05e04124bcc8d3)

BibTeX

@misc{dcd9eb4e44bbc7,
  title = {Triple M Syndrome Associated With Concurrent Durvalumab and Olaparib Therapy in Metastatic Cholangiocarcinoma: A Case Report — Europe PMC PMID:42338513},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42338513},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d9eb4e44bbc7; sha256 715a177ebc10384640b035a48466cf837f7353819932da21ad05e04124bcc8d3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42338513. Agents can read the archived copy with the MCP tool read_document.